Elixir Pharmaceuticals, Inc.
Records under this name other than patents Elixir Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Elixir Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,486,990 | SirT inhibitors that bind to NAD Formerly held Term ended Term ended Nov 20, 2024 · From the USPTO record | Term ended | Term ended Nov 20, 2024 | From the USPTO record |
| US 7,897,765 | Therapeutic compounds and uses thereof Lapsed on the fee record Ended Mar 1, 2015 · From the USPTO record | Lapsed on the fee record | Ended Mar 1, 2015 | From the USPTO record |
| US 7,829,589 | Sulfonamide compounds and uses thereof Lapsed on the fee record Ended Nov 9, 2014 · From the USPTO record | Lapsed on the fee record | Ended Nov 9, 2014 | From the USPTO record |
| US 7,771,961 | Cytochrome c acetylation Lapsed on the fee record Ended Aug 10, 2014 · From the USPTO record | Lapsed on the fee record | Ended Aug 10, 2014 | From the USPTO record |
| US 7,575,883 | Cytochrome c acetylation Lapsed on the fee record Ended Aug 18, 2013 · From the USPTO record | Lapsed on the fee record | Ended Aug 18, 2013 | From the USPTO record |
| US 7,504,506 | Therapeutic Compounds and Uses Thereof Lapsed on the fee record Ended Mar 17, 2013 · High confidence | Lapsed on the fee record | Ended Mar 17, 2013 | High confidence |